DEVELOPMENT OF TETHERED HSP90 INHIBITORS CARRYING RADIOIODINATED PROBES TO SPECIFICALLY DISCRIMINATE AND KILL MALIGNANT BREAST TUMOR CELLS

$1,109,819FY2015Department of DefenseDOD

Duke University, Durham NC

Investigators